Relafen


Also found in: Thesaurus, Medical.
Related to Relafen: Norflex
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Relafen - a nonsteroidal anti-inflammatory drug (trade name Relafen)
nonsteroidal anti-inflammatory, nonsteroidal anti-inflammatory drug, NSAID - an anti-inflammatory drug that does not contain steroids; "NSAIDs inhibit the activity of both Cox-1 and Cox-2 enzymes"
ketone - any of a class of organic compounds having a carbonyl group linked to a carbon atom in each of two hydrocarbon radicals
brand, brand name, marque, trade name - a name given to a product or service
References in periodicals archive ?
NSAIDs Include: Tricosal, Arthropan, celebrex, Voltaren, Indocin, etodolac, Ibuprofen, Ponstel, Relafen, Sodium salicylate
Several generic versions of Nabumetone are already on the market under brand names including Relifex and Relafen.
People taking NSAIDs (Motrin, Clinoril, Relafen, etc.
Other notable cases include litigation involving the TAP Pharmaceutical's Lupron litigation; GlaxoSmithKline's Relafen litigation; Exxon Valdez oil spill; Louisiana Pacific Siding; Nordstrom; and Boston Chicken.
Drug giant GlaxoSmithKline will see its profits hit by a pounds 220m legal charge after settling a US anti-trust case over its arthritis drug Relafen.
ibuprofen, Advil, Naprosyn, Relafen, Aleve) 1 week before the procedure.
NSAIDs Used To Treat Lupus(*) Generic Name Brand Name Ibuprofen Motrin, Advil Naproxen Naprosyn, Aleve Sulindac Clinoril Diclofenac Voltaren Piroxicam Feldene Ketoprofen Orudis Diflunisal Dolobid Nabumetone Relafen Etodolac Lodine Oxaprozin Daypro Indomethacin Indocin (*) Brand names included in this fact sheet are provided as examples only and their inclusion does not mean that these products are endorsed by the National Institutes of Health or any other Government agency.
9 billion in 1998, Relafen had $450 million, and Daypro had $300 million.
SmithKline's key drugs for the future are its Paxil/Seroxat antidepressant, which has been taking market share in a growing market from the leading new-generation antidepressant of this type, Eli Lilly & Co's Prozac; the boosted antibiotic Augmentin and the painkilling Relafen.